Methyl 2-amino-4-bromo-5-methoxybenzoate

Catalog No. :
ACLXAO541
CAS No. :
1256955-36-8
Molecular Formula :
C9H10BrNO3
Molecular Weight :
260.09

IUPAC Name:methyl 2-amino-4-bromo-5-methoxybenzoate

Methyl 2-amino-4-bromo-5-methoxybenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$65.00Login to see priceIn stockIn stock
5g97%$214.00Login to see priceIn stockIn stock
25g97%$761.00Login to see priceIn stockIn stock
100g97%$2618.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-amino-4-bromo-5-methoxybenzoate
IUPAC Namemethyl 2-amino-4-bromo-5-methoxybenzoate
MDL No.MFCD28400710
Molecular FormulaC9H10BrNO3
Molecular Weight260.09
SMILESO=C(OC)C1=CC(OC)=C(Br)C=C1N
InChI KeyVLYQTTVQFZRGQX-UHFFFAOYSA-N
Synonymmethyl 2-amino-4-bromo-5-methoxybenzoate | 1256955-36-8 | 2-Amino-4-bromo-5-methoxy-benzoic acid methyl ester | methyl 2-amino-4-bromo-5-methoxy-benzoate | SCHEMBL858261 | Benzoic acid, 2-amino-4-bromo-5-methoxy-, methyl ester | MFCD28400710 | PB40115 | m
CAS No.1256955-36-8
PubChem CID66820543

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLXAO541 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACICZH324 route compound structure diagram
    ACICZH3241623120-78-4 In Stock
  2. Then
  3. ACLXAO541 route product structure diagram
    ACLXAO5411256955-36-8 In Stock
Inquiry

2. ACLXAO541 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACNOIR604 route compound structure diagram
    ACNOIR6041623120-79-5 In Stock
  4. Then
  5. ACLXAO541 route product structure diagram
    ACLXAO5411256955-36-8 In Stock
Inquiry

Comments (0)